Cogent Biosciences Inc. (COGT)
NASDAQ: COGT
· Real-Time Price · USD
5.29
-0.15 (-2.76%)
At close: Jun 02, 2025, 12:08 PM
-2.76% (1D)
| Bid | 4.32 |
| Market Cap | 601.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -269.5M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -2.68 |
| Forward PE | -2.9 |
| Analyst | Buy |
| Ask | 6.55 |
| Volume | 1,396,011 |
| Avg. Volume (20D) | 1,324,115 |
| Open | 5.85 |
| Previous Close | 5.44 |
| Day's Range | 5.10 - 6.10 |
| 52-Week Range | 3.72 - 12.61 |
| Beta | 0.22 |
About COGT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COGT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COGT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+12.91%
Cogent Biosciences shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
-15.84%
Cogent Biosciences shares are trading lower after the company announced Bezuclantinib presentations at the 66th annual American Society of Hematology meeting.
